Dwayne C. Jones

Array ( [id] => 17391963 [patent_doc_number] => RE048923 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-02-08 [patent_title] => Crystal forms [patent_app_type] => reissue [patent_app_number] => 15/830544 [patent_app_country] => US [patent_app_date] => 2017-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17217 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14481199 [patent_doc_number] => RE047451 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-06-25 [patent_title] => Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases [patent_app_type] => reissue [patent_app_number] => 15/783240 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26321 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15066915 [patent_doc_number] => RE047689 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-11-05 [patent_title] => Compounds for treating spinal muscular atrophy [patent_app_type] => reissue [patent_app_number] => 15/695299 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 37 [patent_no_of_words] => 99733 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 301 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15781093 [patent_doc_number] => RE047954 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-04-21 [patent_title] => Combination therapy with peptide epoxyketones [patent_app_type] => reissue [patent_app_number] => 15/639727 [patent_app_country] => US [patent_app_date] => 2017-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16977 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15639727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14054171 [patent_doc_number] => RE047302 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-03-19 [patent_title] => Peptide epoxyketone immunoproteasome inhibitors [patent_app_type] => reissue [patent_app_number] => 15/631276 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59049 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13884065 [patent_doc_number] => RE047221 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-02-05 [patent_title] => Tricyclic compounds [patent_app_type] => reissue [patent_app_number] => 15/446102 [patent_app_country] => US [patent_app_date] => 2017-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 162195 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14635975 [patent_doc_number] => RE047539 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-07-30 [patent_title] => Aza-dibenzocyclooctynes and methods of making and using same [patent_app_type] => reissue [patent_app_number] => 15/381634 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8462 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14515045 [patent_doc_number] => RE047475 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-07-02 [patent_title] => Selective agents for pain suppression [patent_app_type] => reissue [patent_app_number] => 15/267953 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 62 [patent_no_of_words] => 41259 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15267953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14001977 [patent_doc_number] => RE047267 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-03-05 [patent_title] => Pyridinecarboxamides as CXCR2 modulators [patent_app_type] => reissue [patent_app_number] => 15/177218 [patent_app_country] => US [patent_app_date] => 2016-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20778 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15177218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13150433 [patent_doc_number] => RE047078 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-10-09 [patent_title] => Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide [patent_app_type] => reissue [patent_app_number] => 15/172283 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 6699 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13115459 [patent_doc_number] => RE047047 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-09-18 [patent_title] => 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents [patent_app_type] => reissue [patent_app_number] => 15/080187 [patent_app_country] => US [patent_app_date] => 2016-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11904 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12245661 [patent_doc_number] => RE046757 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-03-20 [patent_title] => 'Pyridine and pyrazine derivative for the treatment of CF' [patent_app_type] => reissue [patent_app_number] => 14/755691 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39555 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14755691 [rel_patent_id] =>[rel_patent_doc_number] =>)